scholarly journals How robust are cross-population signatures of polygenic adaptation in humans?

2020 ◽  
Author(s):  
Alba Refoyo-Martínez ◽  
Siyang Liu ◽  
Anja Moltke Jørgensen ◽  
Xin Jin ◽  
Anders Albrechtsen ◽  
...  

AbstractOver the past decade, summary statistics from genome-wide association studies (GWAS) have been used to detect and quantify polygenic adaptation in humans. Several studies have reported signatures of natural selection at sets of SNPs associated with complex traits, like height and body mass index. However, more recent studies suggest that some of these signals may be caused by biases from uncorrected population stratification in the GWAS data with which these tests are performed. Moreover, past studies have predominantly relied on SNP effect size estimates obtained from GWAS panels of European ancestries, which are known to be poor predictors of phenotypes in non-European populations. Here, we collated GWAS data from multiple anthropometric and metabolic traits that have been measured in more than one cohort around the world, including the UK Biobank, FINRISK, Chinese NIPT, Biobank Japan, APCDR and PAGE. We then evaluated how robust signals of polygenic adaptation are to the choice of GWAS cohort used to identify associated variants and their effect size estimates, while using the same panel to obtain population allele frequencies (The 1000 Genomes Project). We observe many discrepancies across tests performed on the same phenotype and find that association studies performed using multiple different cohorts, like meta-analyses, tend to produce scores with strong overdispersion across populations. This results in apparent signatures of polygenic adaptation which are not observed when using effect size estimates from biobank-based GWAS of homogeneous ancestries. Indeed, we were able to artificially create score overdispersion when taking the UK Biobank cohort and simulating a meta-analysis on multiple subsets of the cohort. This suggests that extreme caution should be taken in the execution and interpretation of future tests of polygenic adaptation based on population differentiation, especially when using summary statistics from GWAS meta-analyses.

2017 ◽  
Author(s):  
Jeremy J. Berg ◽  
Xinjun Zhang ◽  
Graham Coop

AbstractOur understanding of the genetic basis of human adaptation is biased toward loci of large pheno-typic effect. Genome wide association studies (GWAS) now enable the study of genetic adaptation in polygenic phenotypes. We test for polygenic adaptation among 187 world-wide human populations using polygenic scores constructed from GWAS of 34 complex traits. We identify signals of polygenic adaptation for anthropometric traits including height, infant head circumference (IHC), hip circumference and waist-to-hip ratio (WHR). Analysis of ancient DNA samples indicates that a north-south cline of height within Europe and and a west-east cline across Eurasia can be traced to selection for increased height in two late Pleistocene hunter gatherer populations living in western and west-central Eurasia. Our observation that IHC and WHR follow a latitudinal cline in Western Eurasia support the role of natural selection driving Bergmann’s Rule in humans, consistent with thermoregulatory adaptation in response to latitudinal temperature variation.Author’s Note on Failure to ReplicateAfter this preprint was posted, the UK Biobank dataset was released, providing a new and open GWAS resource. When attempting to replicate the height selection results from this preprint using GWAS data from the UK Biobank, we discovered that we could not. In subsequent analyses, we determined that both the GIANT consortium height GWAS data, as well as another dataset that was used for replication, were impacted by stratification issues that created or at a minimum substantially inflated the height selection signals reported here. The results of this second investigation, written together with additional coauthors, have now been published (https://elifesciences.org/articles/39725 along with another paper by a separate group of authors, showing similar issues https://elifesciences.org/articles/39702). A preliminary investigation shows that the other non-height based results may suffer from similar issues. We stand by the theory and statistical methods reported in this paper, and the paper can be cited for these results. However, we have shown that the data on which the major empirical results were based are not sound, and so should be treated with caution until replicated.


Author(s):  
Jack W. O’Sullivan ◽  
John P. A. Ioannidis

AbstractWith the establishment of large biobanks, discovery of single nucleotide polymorphism (SNPs) that are associated with various phenotypes has been accelerated. An open question is whether SNPs identified with genome-wide significance in earlier genome-wide association studies (GWAS) are replicated also in later GWAS conducted in biobanks. To address this question, the authors examined a publicly available GWAS database and identified two, independent GWAS on the same phenotype (an earlier, “discovery” GWAS and a later, replication GWAS done in the UK biobank). The analysis evaluated 136,318,924 SNPs (of which 6,289 had reached p<5e-8 in the discovery GWAS) from 4,397,962 participants across nine phenotypes. The overall replication rate was 85.0% and it was lower for binary than for quantitative phenotypes (58.1% versus 94.8% respectively). There was a18.0% decrease in SNP effect size for binary phenotypes, but a 12.0% increase for quantitative phenotypes. Using the discovery SNP effect size, phenotype trait (binary or quantitative), and discovery p-value, we built and validated a model that predicted SNP replication with area under the Receiver Operator Curve = 0.90. While non-replication may often reflect lack of power rather than genuine false-positive findings, these results provide insights about which discovered associations are likely to be seen again across subsequent GWAS.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jack W. O’Sullivan ◽  
John P. A. Ioannidis

AbstractWith the establishment of large biobanks, discovery of single nucleotide variants (SNVs, also known as single nucleotide polymorphisms (SNVs)) associated with various phenotypes has accelerated. An open question is whether genome-wide significant SNVs identified in earlier genome-wide association studies (GWAS) are replicated in later GWAS conducted in biobanks. To address this, we examined a publicly available GWAS database and identified two, independent GWAS on the same phenotype (an earlier, “discovery” GWAS and a later, “replication” GWAS done in the UK biobank). The analysis evaluated 136,318,924 SNVs (of which 6289 reached P < 5e−8 in the discovery GWAS) from 4,397,962 participants across nine phenotypes. The overall replication rate was 85.0%; although lower for binary than quantitative phenotypes (58.1% versus 94.8% respectively). There was a 18.0% decrease in SNV effect size for binary phenotypes, but a 12.0% increase for quantitative phenotypes. Using the discovery SNV effect size, phenotype trait (binary or quantitative), and discovery P value, we built and validated a model that predicted SNV replication with area under the Receiver Operator Curve = 0.90. While non-replication may reflect lack of power rather than genuine false-positives, these results provide insights about which discovered associations are likely to be replicated across subsequent GWAS.


2018 ◽  
Vol 35 (14) ◽  
pp. 2495-2497 ◽  
Author(s):  
Gregory McInnes ◽  
Yosuke Tanigawa ◽  
Chris DeBoever ◽  
Adam Lavertu ◽  
Julia Eve Olivieri ◽  
...  

Abstract Summary Large biobanks linking phenotype to genotype have led to an explosion of genetic association studies across a wide range of phenotypes. Sharing the knowledge generated by these resources with the scientific community remains a challenge due to patient privacy and the vast amount of data. Here, we present Global Biobank Engine (GBE), a web-based tool that enables exploration of the relationship between genotype and phenotype in biobank cohorts, such as the UK Biobank. GBE supports browsing for results from genome-wide association studies, phenome-wide association studies, gene-based tests and genetic correlation between phenotypes. We envision GBE as a platform that facilitates the dissemination of summary statistics from biobanks to the scientific and clinical communities. Availability and implementation GBE currently hosts data from the UK Biobank and can be found freely available at biobankengine.stanford.edu.


2017 ◽  
Author(s):  
Sina Rüeger ◽  
Aaron McDaid ◽  
Zoltán Kutalik

AbstractAs most of the heritability of complex traits is attributed to common and low frequency genetic variants, imputing them by combining genotyping chips and large sequenced reference panels is the most cost-effective approach to discover the genetic basis of these traits. Association summary statistics from genome-wide meta-analyses are available for hundreds of traits. Updating these to ever-increasing reference panels is very cumbersome as it requires reimputation of the genetic data, rerunning the association scan, and meta-analysing the results. A much more efficient method is to directly impute the summary statistics, termed as summary statistics imputation. Its performance relative to genotype imputation and practical utility has not yet been fully investigated. To this end, we compared the two approaches on real (genotyped and imputed) data from 120K samples from the UK Biobank and show that, while genotype imputation boasts a 2- to 5-fold lower root-mean-square error, summary statistics imputation better distinguishes true associations from null ones: We observed the largest differences in power for variants with low minor allele frequency and low imputation quality. For fixed false positive rates of 0.001, 0.01, 0.05, using summary statistics imputation yielded an increase in statistical power by 15, 10 and 3%, respectively. To test its capacity to discover novel associations, we applied summary statistics imputation to the GIANT height meta-analysis summary statistics covering HapMap variants, and identified 34 novel loci, 19 of which replicated using data in the UK Biobank. Additionally, we successfully replicated 55 out of the 111 variants published in an exome chip study. Our study demonstrates that summary statistics imputation is a very efficient and cost-effective way to identify and fine-map trait-associated loci. Moreover, the ability to impute summary statistics is important for follow-up analyses, such as Mendelian randomisation or LD-score regression.Author summaryGenome-wide association studies (GWASs) quantify the effect of genetic variants and traits, such as height. Such estimates are called association summary statistics and are typically publicly shared through publication. Typically, GWASs are carried out by genotyping ~ 500′000 SNVs for each individual which are then combined with sequenced reference panels to infer untyped SNVs in each’ individuals genome. This process of genotype imputation is resource intensive and can therefore be a limitation when combining many GWASs. An alternative approach is to bypass the use of individual data and directly impute summary statistics. In our work we compare the performance of summary statistics imputation to genotype imputation. Although we observe a 2- to 5-fold lower RMSE for genotype imputation compared to summary statistics imputation, summary statistics imputation better distinguishes true associations from null results. Furthermore, we demonstrate the potential of summary statistics imputation by presenting 34 novel height-associated loci, 19 of which were confirmed in UK Biobank. Our study demonstrates that given current reference panels, summary statistics imputation is a very efficient and cost-effective way to identify common or low-frequency trait-associated loci.


2018 ◽  
Author(s):  
Gregory McInnes ◽  
Yosuke Tanigawa ◽  
Chris DeBoever ◽  
Adam Lavertu ◽  
Julia Eve Olivieri ◽  
...  

Large biobanks linking phenotype to genotype have led to an explosion of genetic association studies across a wide range of phenotypes. Sharing the knowledge generated by these resources with the scientific community remains a challenge due to patient privacy and the vast amount of data. Here we present Global Biobank Engine (GBE), a web-based tool that enables the exploration of the relationship between genotype and phenotype in large biobank cohorts, such as the UK Biobank. GBE supports browsing for results from genome-wide association studies, phenome-wide association studies, gene-based tests, and genetic correlation between phenotypes. We envision GBE as a platform that facilitates the dissemination of summary statistics from biobanks to the scientific and clinical communities. GBE currently hosts data from the UK Biobank and can be found freely available at biobankengine.stanford.edu.


2021 ◽  
Author(s):  
Jack W. O’Sullivan ◽  
John P . A. Ioannidis

Abstract With the establishment of large biobanks, discovery of single nucleotide polymorphism (SNPs) associated with various phenotypes has accelerated. An open question is whether genome-wide significant SNPs identified in earlier genome-wide association studies (GWAS) are replicated in later GWAS conducted in biobanks. To address this, we examined a publicly available GWAS database and identified two, independent GWAS on the same phenotype (an earlier, “discovery” GWAS and a later, “replication” GWAS done in UK biobank). The analysis evaluated 136,318,924 SNPs (of which 6,289 reached p<5e-8 in the discovery GWAS) from 4,397,962 participants across nine phenotypes. The overall replication rate was 85.0%; although lower for binary than quantitative phenotypes (58.1% versus 94.8% respectively). There was a 18.0% decrease in SNP effect size for binary phenotypes, but a 12.0% increase for quantitative phenotypes. Using the discovery SNP effect size, phenotype trait (binary or quantitative), and discovery p-value, we built and validated a model that predicted SNP replication with area under the Receiver Operator Curve = 0.90. While non-replication may reflect lack of power rather than genuine false-positives, these results provide insights about which discovered associations are likely to be replicated across subsequent GWAS.


2018 ◽  
Author(s):  
Jeremy J. Berg ◽  
Arbel Harpak ◽  
Nasa Sinnott-Armstrong ◽  
Anja Moltke Jørgensen ◽  
Hakhamanesh Mostafavi ◽  
...  

AbstractSeveral recent papers have reported strong signals of selection on European polygenic height scores. These analyses used height effect estimates from the GIANT consortium and replication studies. Here, we describe a new analysis based on the the UK Biobank (UKB), a large, independent dataset. We find that the signals of selection using UKB effect-size estimates for height are strongly attenuated or absent. We also provide evidence that previous analyses were confounded by population stratification Therefore, the conclusion of strong polygenic adaptation now lacks support. Moreover, these discrepancies highlight (1) that methods for correcting for population stratification in GWAS may not always be sufficient for polygenic trait analyses, and (2) that claims of differences in polygenic scores between populations should be treated with caution until these issues are better understood.


2021 ◽  
Author(s):  
Abhishek Nag ◽  
Lawrence Middleton ◽  
Ryan S Dhindsa ◽  
Dimitrios Vitsios ◽  
Eleanor M Wigmore ◽  
...  

Genome-wide association studies have established the contribution of common and low frequency variants to metabolic biomarkers in the UK Biobank (UKB); however, the role of rare variants remains to be assessed systematically. We evaluated rare coding variants for 198 metabolic biomarkers, including metabolites assayed by Nightingale Health, using exome sequencing in participants from four genetically diverse ancestries in the UKB (N=412,394). Gene-level collapsing analysis, that evaluated a range of genetic architectures, identified a total of 1,303 significant relationships between genes and metabolic biomarkers (p<1x10-8), encompassing 207 distinct genes. These include associations between rare non-synonymous variants in GIGYF1 and glucose and lipid biomarkers, SYT7 and creatinine, and others, which may provide insights into novel disease biology. Comparing to a previous microarray-based genotyping study in the same cohort, we observed that 40% of gene-biomarker relationships identified in the collapsing analysis were novel. Finally, we applied Gene-SCOUT, a novel tool that utilises the gene-biomarker association statistics from the collapsing analysis to identify genes having similar biomarker fingerprints and thus expand our understanding of gene networks.


Sign in / Sign up

Export Citation Format

Share Document